High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation
Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study Group
Robison LL, Nesbit ME Jr, Sather HN et al. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. J Pediarr 1984: 105: 235-242.
Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukemia
letter
Blatt J, Albo V, Prin W et al. Excessive chemotherapy-related myelotoxicity in children with Down syndrome and acute lymphoblastic leukemia. Lancet 1986; 2: 914 (letter).
Bone marrow transplantation for children with acute leukemia and Down syndrome
Rubin CM, O'Leary M, Koch PA. Nesbit ME Jr. Bone marrow transplantation for children with acute leukemia and Down syndrome. Pediatrics 1986; 78: 688-691.
Bone marrow transplantation for acute leukemia and Down syndrome: Report of a successful case and results of a national survey
Arenson EB Jr, Forde MD. Bone marrow transplantation for acute leukemia and Down syndrome: report of a successful case and results of a national survey. J Pediatr 1989; 114: 69-72.
Superior outcome in Down's syndrome children with acute myeloid leukemia: Possible link between sensitivity to methotrexate and response to cytosine arabinoside
abstr.
Ravindranath Y, Abella E. Krischer JP et al. Superior outcome in Down's syndrome children with acute myeloid leukemia: possible link between sensitivity to methotrexate and response to cytosine arabinoside. Med Pediatr Oncol 1992; 20: 373 (abstr.).
Enhanced formation of cytarabine triphosphate (Ara-CTP) in Down syndrome cells: Possible explanation for superior disease-free survival of Down syndrome children with acute myeloid leukemia
abstr.
Taub JW, Matherly LH, Buck SA et al. Enhanced formation of cytarabine triphosphate (Ara-CTP) in Down syndrome cells: possible explanation for superior disease-free survival of Down syndrome children with acute myeloid leukemia. Blood 1994; 81 (suppl. 1): 515a (abstr.).
Bone marrow transplantation for severe aplastic anemia: Influence of conditioning regimen and graft-versus-host prophylaxis regimens on outcome
Gluckman E, Horowitz MM, Champlin RE et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning regimen and graft-versus-host prophylaxis regimens on outcome. Blood 1992; 79: 269-276.
Marrow transplantation in patients with thalassemia responsive to iron chelation therapy
Lucarelli G. Galimberti M, Polchi P et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. New Engl J Med 1993; 329: 840-844.